Jiuzhitang Maker signed the Agreement on Co-construction of Stem Cells Clinical Research Base with Beijing Tiantan Hospital.
In August 2018, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. signed Agreement on Co-construction of Stem Cell Clinical Research Base with Beijing Tiantan Hospital, which states the Parties’ priority of rolling out stem cell clinical studies on indications of interest. Specifically, a renowned neurological expert from Tiantan Hospital will serve as Principal Investigator for the two clinical trials of “Using Stem Cells to treat Cerebral Stroke” and “Using Stem Cells to Treat Alzheimer’s” sponsored by Maker. In the long term, Maker and Titan Hospital are committed to launching more studies on the efficacy of stem cell drugs, and further exploring the potential of treating additional indications with stem cells.
Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
